İlknur Erdem

451 total citations
17 papers, 274 citations indexed

About

İlknur Erdem is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, İlknur Erdem has authored 17 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Applied Microbiology and Biotechnology. Recurrent topics in İlknur Erdem's work include Antibiotic Use and Resistance (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Nosocomial Infections in ICU (4 papers). İlknur Erdem is often cited by papers focused on Antibiotic Use and Resistance (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Nosocomial Infections in ICU (4 papers). İlknur Erdem collaborates with scholars based in Türkiye and United States. İlknur Erdem's co-authors include Jan Pohl, H. Anne Pereira, John K. Spitznagel, Paşa Göktaş, Nurgül Ceran, Derya Öztürk-Engin, Asu Özgültekin, Güldem Turan, Seniha Şenbayrak and Emine Dinçer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Microbiology and Infection and International Journal of Antimicrobial Agents.

In The Last Decade

İlknur Erdem

17 papers receiving 263 citations

Peers

Countries citing papers authored by İlknur Erdem

Since Specialization

Citations

This map shows the geographic impact of İlknur Erdem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İlknur Erdem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İlknur Erdem more than expected).

Fields of papers citing papers by İlknur Erdem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İlknur Erdem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İlknur Erdem. The network helps show where İlknur Erdem may publish in the future.

Co-authorship network of co-authors of İlknur Erdem

This figure shows the co-authorship network connecting the top 25 collaborators of İlknur Erdem. A scholar is included among the top collaborators of İlknur Erdem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İlknur Erdem. İlknur Erdem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Epidemiology and prognosis of sepsis in cancer patients: A multicenter prospective observational study 2025 ·The American Journal of the Medical Sciences ·Zeynep Türe, (unknown), (unknown), (unknown), Ayşe Kaya Kalem, Esma Eren, (unknown), (unknown), Emel Azak, İlknur Erdem, Jordi Rello, Emine Alp	2
2	The incidence of acute kidney injury and its association with mortality in patients diagnosed withCOVID‐19 followed up in intensive care unit 2022 ·Therapeutic Apheresis and Dialysis ·(unknown), Gülsüm Özkan, (unknown), (unknown), İlknur Erdem, Nazan Tuna, Levent Cem Mutlu, (unknown), Nuri̇ Kiraz, Berna Erdal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	7
3	A 5-year surveillance of healthcare-associated infections in a university hospital: A retrospective analysis 2022 ·SAGE Open Medicine ·İlknur Erdem, (unknown), (unknown), Rıdvan Karaali, Berna Erdal, (unknown), Mustafa Doğan, (unknown), (unknown), (unknown), (unknown), Birol Topçu, Nuri̇ Kiraz, (unknown)	7
4	Comparison of antibiotic use in the COVID-19 pandemic with the pre-pandemic period in a university hospital 2022 ·Archives of Medical Science ·İlknur Erdem, (unknown), (unknown), (unknown), (unknown)	2
5	A Case of Acute Cholestatic Hepatitis Due to Epstein-Barr Virus Infection 2020 ·Klimik Dergisi/Klimik Journal ·(unknown), Rıdvan Karaali, (unknown), (unknown), (unknown), Mustafa Doğan, (unknown), İlknur Erdem	2
6	A rare cause of fever in an adult: a case of familial Mediterranean fever 2018 ·International Medical Case Reports Journal ·İlknur Erdem, (unknown), Rıdvan Karaali, (unknown), (unknown), (unknown), (unknown), (unknown)	1
7	Community-acquired lower urinary tract infections: Etiology, antimicrobial resistance, and treatment results in female patients 2018 ·Journal of Global Infectious Diseases ·İlknur Erdem, (unknown), (unknown), (unknown), (unknown), (unknown)	32
8	Alterations in Bacterial Spectrum and Increasing Resistance Rates in Isolated Microorganisms from Device-Associated Infections in an Intensive Care Unit of a Teaching Hospital in Istanbul (2004–2010) 2012 ·Japanese Journal of Infectious Diseases ·Asuman İnan, Asu Özgültekin, Seniha Şenbayrak, Derya Öztürk-Engin, Güldem Turan, Nurgül Ceran, Emine Dinçer, Sebahat Aksaray, Paşa Göktaş, İlknur Erdem	15
9	A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections 2010 ·Journal of Infection and Chemotherapy ·Nurgül Ceran, (unknown), (unknown), İlknur Erdem, (unknown), Paşa Göktaş, (unknown)	34
10	Incidence, Etiology and Risk Factors Associated with Mortality of Nosocomial Candidemia in a Tertiary Care Hospital in Istanbul, Turkey 2010 ·Medical Principles and Practice ·İlknur Erdem, (unknown), Derya Öztürk-Engin, Asu Özgültekin, (unknown), Nurgül Ceran, Fatma Nur Kaya, (unknown), Paşa Göktaş	12
11	Bloodstream infections in a medical–surgical intensive care unit: incidence, aetiology, antimicrobial resistance patterns of Gram-positive and Gram-negative bacteria 2009 ·Clinical Microbiology and Infection ·İlknur Erdem, Asu Özgültekin, (unknown), Derya Öztürk-Engin, Seniha Şenbayrak, Güldem Turan, Emine Dinçer, (unknown), Paşa Göktaş	17
12	Incidence, Etiology, and Antibiotic Resistance Patterns of Gram-Negative Microorganisms Isolated from Patients with Ventilator-Associated Pneumonia in a Medical-Surgical Intensive Care Unit of a Teaching Hospital in Istanbul, Turkey (2004-2006) 2008 ·Japanese Journal of Infectious Diseases ·İlknur Erdem, Asu Özgültekin, Asuman İnan, Emine Dinçer, Güldem Turan, Nurgül Ceran, Derya Öztürk-Engin, Seniha Şenbayrak, Nur Akgün, Paşa Göktaş	21
13	In vitro Activity of Combination Therapy with Cefepime, Piperacillin-Tazobactam, or Meropenem with Ciprofloxacin against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Strains 2003 ·Chemotherapy ·İlknur Erdem, (unknown), Nurgül Ceran	17
14	In vitro effect of levofloxacin and vancomycin combination against high level aminoglycoside-resistant enterococci 2003 ·International Journal of Antimicrobial Agents ·İlknur Erdem	1
15	The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains 2002 ·International Journal of Antimicrobial Agents ·İlknur Erdem, (unknown), (unknown), Paşa Göktaş	16
16	Bactericidal activity of the fluoroquinolone DU-6859a alone and in combination with other antimicrobial agents against multiresistant enterococci 1996 ·Diagnostic Microbiology and Infectious Disease ·Volkan Korten, İlknur Erdem, B E Murray	7
17	Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. 1993 ·Proceedings of the National Academy of Sciences ·H. Anne Pereira, İlknur Erdem, Jan Pohl, John K. Spitznagel	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact